<DOC>
	<DOCNO>NCT01465828</DOCNO>
	<brief_summary>Dual antiplatelet therapy aspirin Clopidogrel least one year essential patient follow acute coronary syndrome ( ACS ) percutaneous coronary intervention ( PCI ) drug elute stent ( s. Interindividual variability platelet response clopidogrel report , several mechanism implicate high post-clopidogrel treatment PR . High on-treatment platelet reactivity ( HTPR ) associate increase risk adverse event PCI . Studies patient chronic clopidogrel treatment scarce , mainly diabetic patient HTPR frequently present independently predictive adverse event . Optimization platelet inhibition patient HTPR increase clopidogrel alternatively , potent P2Y12 inhibitor controversial issue , mostly study post PCI patient , data exist , best investigator knowledge , stable patient chronic clopidogrel treatment . Therefore HTPR patient , accept participate , enrol randomize ( Day 0 ) 1:1 ratio either clopidogrel 150 mg day , prasugrel 10 mg day , Day 14 post randomization . A 14 ± 2 day visit perform PR measurement safety evaluation , blood sample obtain 16-18 hour last study-drug dose , follow crossover directly alternate therapy additional 14 day without intervene washout period . At Day 28 ± 2 patient return clinical laboratory assessment Day 14 visit .</brief_summary>
	<brief_title>Therapy With High Clopidogrel Dose Prasugrel Standard Dose Reduces Platelet Reactivity Patients With Genotype Variation RESET GENE Trial</brief_title>
	<detailed_description />
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Prasugrel Hydrochloride</mesh_term>
	<criteria>patient underwent PCI lopidogrel resistance Platelet reactivity blood test history bleed diathesis chronic oral anticoagulation treatment contraindication antiplatelet therapy PCI coronary artery bypass grafting ( CABG ) &lt; 3 month hemodynamic instability platelet count &lt; 100,000/μl hematocrit &lt; 30 % creatinine clearance &lt; 25 ml/min Patients history stroke contraindication prasugrel administration patient weigh &lt; 60 kg &gt; 75 year age .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>antiplatelet effect</keyword>
	<keyword>prasugrel</keyword>
	<keyword>clopidogrel</keyword>
	<keyword>ACS</keyword>
</DOC>